You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Darell Bigner

Showing 1 - 16 of 16
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Newly Diagnosed MGMT Unmethylated Glioblastoma Trial in Durham (D2C7-IT, 2141-V11)

Not yet recruiting
  • Newly Diagnosed MGMT Unmethylated Glioblastoma
  • Durham, North Carolina
    Duke University Medical Center
Feb 7, 2023

Glioma, Malignant Trial in Durham (D2C7-IT, 2141-V11)

Recruiting
  • Glioma, Malignant
  • Durham, North Carolina
    Duke University Medical Center
Jul 27, 2022

Malignant Glioma, Brain Tumor, Recurrent Trial in Durham (D2C7-IT)

Active, not recruiting
  • Malignant Glioma
  • Brain Tumor, Recurrent
  • Durham, North Carolina
    Preston Robert Tisch Brain Tumor Center at Duke
Jul 12, 2022

Malignant Glioma Trial in Durham (D2C7-IT (6920 ng/mL via convection-enhanced delivery), Atezolizumab (1200 mg every three

Recruiting
  • Malignant Glioma
  • D2C7-IT (6920 ng/mL via convection-enhanced delivery)
  • +2 more
  • Durham, North Carolina
    Duke University Medical Center
Mar 22, 2022

Invasive Breast Cancer Trial in Durham (PVSRIPO)

Recruiting
  • Invasive Breast Cancer
  • PVSRIPO
  • Durham, North Carolina
    Duke University Medical Center
Aug 4, 2021

Malignant Glioma Trial (PVSRIPO, Atezolizumab)

Withdrawn
  • Malignant Glioma
  • (no location specified)
Feb 7, 2020

Melanoma Trial in Durham (PVSRIPO, Nivolumab)

Withdrawn
  • Melanoma
  • Durham, North Carolina
    Duke University Medical Center
Feb 7, 2020

Brain and CNS Tumors, Neuroblastoma Trial in Durham (drug, procedure, radiation)

Completed
  • Brain and Central Nervous System Tumors
  • Neuroblastoma
  • Durham, North Carolina
    Duke Comprehensive Cancer Center
Apr 22, 2015

Supratentorial Malignant Brain Tumor Trial in Durham (MR1-1)

Terminated
  • Supratentorial Malignant Brain Tumor
  • MR1-1
  • Durham, North Carolina
    Duke University Health System
Mar 18, 2015

Brain and CNS Tumors, Metastatic Cancer, Neuroblastoma Trial in Durham (surgical procedure, astatine At 211 mAb 81C6)

Completed
  • Brain and Central Nervous System Tumors
  • +2 more
  • surgical procedure
  • astatine At 211 monoclonal antibody 81C6
  • Durham, North Carolina
    Duke Comprehensive Cancer Center
Aug 20, 2014

Brain and CNS Tumors, Metastatic Cancer Trial in Durham (iodine I 131 mAb 81C6)

Completed
  • Brain and Central Nervous System Tumors
  • Metastatic Cancer
  • iodine I 131 monoclonal antibody 81C6
  • Durham, North Carolina
    Duke Comprehensive Cancer Center
Jul 15, 2014

Metastatic Cancer Trial in Durham (mAb Me1-14 F(ab')2)

Completed
  • Metastatic Cancer
  • monoclonal antibody Me1-14 F(ab')2
  • Durham, North Carolina
    Duke Comprehensive Cancer Center
Jun 19, 2013

Brain and CNS Tumors Trial in Durham (iodine I 131 mAb 81C6)

Completed
  • Brain and Central Nervous System Tumors
  • iodine I 131 monoclonal antibody 81C6
  • Durham, North Carolina
    Duke Comprehensive Cancer Center
Feb 15, 2013

Brain and CNS Tumors Trial in Durham, Philadelphia (LMB-7 immunotoxin)

Completed
  • Brain and Central Nervous System Tumors
  • LMB-7 immunotoxin
  • Durham, North Carolina
  • +1 more
Feb 15, 2013

Brain and CNS Tumors, Melanoma (Skin), Metastatic Cancer Trial in Durham (mAb Me1-14 F(ab')2)

Completed
  • Brain and Central Nervous System Tumors
  • +2 more
  • monoclonal antibody Me1-14 F(ab')2
  • Durham, North Carolina
    Duke Comprehensive Cancer Center
Feb 15, 2013

Brain and CNS Tumors Trial in Durham (conventional surgery, iodine I 131 mAb 81C6, radiation therapy)

Completed
  • Brain and Central Nervous System Tumors
  • conventional surgery
  • +2 more
  • Durham, North Carolina
    Duke Comprehensive Cancer Center
Feb 15, 2013